Himuka AM Pharma
Latest round
- Series B
Last raised
- Jan 2022
Total raised
- $5.6M
Investors
- 9
About Himuka AM Pharma
Himuka AM Pharma Corp.Himuka AM Pharma Corp. specializes in developing biopharmaceutical solutions and is headquartered in Miyazaki, Japan.235 million.Himuka AM Pharma Corp. focuses on the research and development of innovative therapeutics, with a particular emphasis on the HM201 product line. HM201 is designed to target specific medical indications, operating within the framework of advanced biopharmaceutical solutions. The company has successfully completed Phase 1 clinical trials for HM201 in Australia, marking a significant milestone in its product development timeline. The end-users of these products primarily include healthcare providers and patients in need of effective therapeutic interventions.Himuka AM Pharma Corp. This collaborative approach facilitates the advancement of HM201 and other pipeline products through systematic testing phases. While specific pricing structures for their products and services have not been disclosed, the firm’s focus on clinical research and development implies a revenue model predicated on successful trial outcomes and subsequent market introductions.In January 2022, Himuka AM Pharma Corp. The company is focusing on advancing the HM201 product line and is exploring opportunities to expand its market presence into new regions, particularly targeting healthcare sectors in Australia and Japan.
Who invested in Himuka AM Pharma
9 investors across 2 rounds
See all investors in Himuka AM Pharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Himuka AM Pharma
Who invested in Himuka AM Pharma?
Himuka AM Pharma has 9 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Himuka AM Pharma raised?
Himuka AM Pharma has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Himuka AM Pharma last raise money?
Himuka AM Pharma's most recent round on record is a Series B, in Jan 2022.
What does Himuka AM Pharma do?
Himuka AM Pharma is a biotechnology company.
Where is Himuka AM Pharma headquartered?
Himuka AM Pharma is headquartered in Miyazaki, Japan.
Which VCs invest in companies like Himuka AM Pharma?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Himuka AM Pharma's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Himuka AM Pharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.